Douglas Harrington's guest appearances

Douglas Harrington

Redefining Medicine

Your Superior Self

Showing Up With Asher Gottesman

The Dark Side Of Music With Derek Hanjora

Eugenia Kuzmina

April Doyle

Andy Kay

Simon Lunche

Arianny Celeste

Rodney Hicks

Kimberly Friedmutter

Doug Bopst

James Kelley

Jimmy Shin

Anis Maknojia

Eben Alexander

Raymond Moody

Peter Attia

Luvvie Ajayi

OwlTail

Dr. Douglas Harrington has over 30 years of experience in the research, development, commercialization, and expansion of innovative healthcare technology and services. As former President and Lab Director of Nichols Institute, Dr. Harrington expanded their molecular genetics, infectious disease, immunology, cytogenetic, and anatomic pathology offerings. Dr. Harrington holds a number of patents including automated image analysis of residual cancer protein, catalytic heavy metal extraction, and biomarker assays for diagnosis and classification of cardiac disease. He has been involved as director or founder of multiple startup companies – from devices to molecular genetics focusing on immunology, cancer and cardiology, where he has taken a number of new molecular technologies through state and federal regulatory approval.

Dr. Douglas Harrington has over 30 years of experience in the research, development, commercialization, and expansion of innovative healthcare technology and services. As former President and Lab Director of Nichols Institute, Dr. Harrington expanded their molecular genetics, infectious disease, immunology, cytogenetic, and anatomic pathology offerings. Dr. Harrington holds a number of patents including automated image analysis of residual cancer protein, catalytic heavy metal extraction, and biomarker assays for diagnosis and classification of cardiac disease. He has been involved as director or founder of multiple startup companies – from devices to molecular genetics focusing on immunology, cancer and cardiology, where he has taken a number of new molecular technologies through state and federal regulatory approval.

Redefining Medicine with special guest Dr. Douglas Harrington

Dr. Douglas Harrington has over 25 years of experience in the research, development, commercialization, and expansion of innovative healthcare technology and services. Dr. Harringtonwas a member of one of the first heart transplant teams led by Dr. Jack Copeland from Stanford University. He-founded one of the first clinical molecular biology laboratories in the U.S. with the Nebraska Lymphoma StudyGroup headed by Dr. Jim Armitage. As President and LabDirector of Nichols Institute, Dr. Harrington expanded their molecular genetics, infectious disease, immunology, cytogenetic, and anatomic pathology offerings. Dr. Harringtonled the team that developed one of the first digital microscopes targeted at minimal residual disease and circulating tumor cells as the founder and CEO of Clarient. Dr.Harrington also led the turnaround and reinstatement of the federal license of Specialty Laboratories, a New York StockExchange company, as CEO and Laboratory Director. Dr. Harrington has developed patents for an automated method for image analysis of residual cancer cells, a patent covering catalytic heavy metal extraction, and a patent-pending on biomarker assay for diagnosis and classification of cardiac disease. He has been involved as a director or founder of multiple startup companies - from devices to molecular genetics focusing on immunology, cancer, and cardiology, where he has taken several new molecular technologies through state and federal regulatory approval and has been involved in the commercialization of over 200 academic discoveries. He is a member of Phi Beta Kappa, the nation's most prestigious academic honor society. Dr. Harrington is the inventor of the PULS Cardiac Test (TM), a breakthrough blood test for the detection of the leading cause of heart attacks, and CEO &amp; Laboratory Director of global Discovery Biosciences. Throughout his career, Dr.Harrington has remained a Clinical Professor of  Pathology at the USC Keck School of medicine, a published author of numerous peer-reviewed papers, and a sought-after speaker in the area of preventive medicine and technology development. Dr. Harrington received his BA in molecular biology, his MD from the University of Colorado HealthSciences Center, and is board-certified in hematology, anatomic and clinical pathology.

Dr. Douglas Harrington has over 25 years of experience in the research, development, commercialization, and expansion of innovative healthcare technology and services. Dr. Harringtonwas a member of one of the first heart transplant teams led by Dr. Jack Copeland from Stanford University. He-founded one of the first clinical molecular biology laboratories in the U.S. with the Nebraska Lymphoma StudyGroup headed by Dr. Jim Armitage. As President and LabDirector of Nichols Institute, Dr. Harrington expanded their molecular genetics, infectious disease, immunology, cytogenetic, and anatomic pathology offerings. Dr. Harringtonled the team that developed one of the first digital microscopes targeted at minimal residual disease and circulating tumor cells as the founder and CEO of Clarient. Dr.Harrington also led the turnaround and reinstatement of the federal license of Specialty Laboratories, a New York StockExchange company, as CEO and Laboratory Director. Dr. Harrington has developed patents for an automated method for image analysis of residual cancer cells, a patent covering catalytic heavy metal extraction, and a patent-pending on biomarker assay for diagnosis and classification of cardiac disease. He has been involved as a director or founder of multiple startup companies - from devices to molecular genetics focusing on immunology, cancer, and cardiology, where he has taken several new molecular technologies through state and federal regulatory approval and has been involved in the commercialization of over 200 academic discoveries. He is a member of Phi Beta Kappa, the nation's most prestigious academic honor society. Dr. Harrington is the inventor of the PULS Cardiac Test (TM), a breakthrough blood test for the detection of the leading cause of heart attacks, and CEO &amp; Laboratory Director of global Discovery Biosciences. Throughout his career, Dr.Harrington has remained a Clinical Professor of  Pathology at the USC Keck School of medicine, a published author of numerous peer-reviewed papers, and a sought-after speaker in the area of preventive medicine and technology development. Dr. Harrington received his BA in molecular biology, his MD from the University of Colorado HealthSciences Center, and is board-certified in hematology, anatomic and clinical pathology.

Guard a Heart- Dr. Douglas Harrington 

Today we show up in a different way than we have on the podcast before. Our guest is Dr. Douglas Harrington, MD Fellow of the American Society of Preventive Cardiology, and the American Society of Clinical Pathology, an expert in laboratory diagnostic testing,  as well as the Chairman of the GUARDaHEART FOUNDATION. We have a frank discussion about the reality of the pandemic. Have the experts been correct? Do masks really work? What is truly causing the spread of COVID-19 and what isn't? We also talk about the vaccine, antibodies, antibody testing as well as if the lockdowns are helpful or harmful. Dr. Harrington shares data that will surprise you. This is a must-listen for everyone right now.  Connect With Dr. Douglas Harrington &amp; GuardAHeart https://www.guardaheart.org/ https://www.facebook.com/Guardaheartfoundation https://twitter.com/guardaheartorg ttps://www.linkedin.com/in/douglas-harrington-14197215/ Connect With Asher Gottesman http://ashergottesman.com/ https://twitter.com/TheAsherG https://www.instagram.com/theasherg/

Today we show up in a different way than we have on the podcast before. Our guest is Dr. Douglas Harrington, MD Fellow of the American Society of Preventive Cardiology, and the American Society of Clinical Pathology, an expert in laboratory diagnostic testing,  as well as the Chairman of the GUARDaHEART FOUNDATION. We have a frank discussion about the reality of the pandemic. Have the experts been correct? Do masks really work? What is truly causing the spread of COVID-19 and what isn't? We also talk about the vaccine, antibodies, antibody testing as well as if the lockdowns are helpful or harmful. Dr. Harrington shares data that will surprise you. This is a must-listen for everyone right now.  Connect With Dr. Douglas Harrington &amp; GuardAHeart <a href="https://www.guardaheart.org/" rel="nofollow" target="_blank">https://www.guardaheart.org/</a> <a href="https://www.facebook.com/Guardaheartfoundation" rel="nofollow" target="_blank">https://www.facebook.com/Guardaheartfoundation</a> <a href="https://twitter.com/guardaheartorg" rel="nofollow" target="_blank">https://twitter.com/guardaheartorg</a> <a href="https://www.linkedin.com/in/douglas-harrington-14197215/" rel="nofollow" target="_blank">ttps://www.linkedin.com/in/douglas-harrington-14197215/</a> Connect With Asher Gottesman <a href="http://ashergottesman.com/" rel="nofollow" target="_blank">http://ashergottesman.com/</a> <a href="https://twitter.com/TheAsherG" rel="nofollow" target="_blank">https://twitter.com/TheAsherG</a><a href="https://twitter.com/TheAsherG" rel="nofollow" target="_blank"> </a><a href="https://www.instagram.com/theasherg/" rel="nofollow" target="_blank">https://www.instagram.com/theasherg/</a>

Dr Douglas Harrington Shows Up To Share The Truth About COVID

Unfortunately, there are many people that are asymptomatic with the coronavirus (not exhibiting any signs or symptoms of active infection) Amid this unprecedented crisis, GUARDaHEART Foundation is working with the communities to offer no-cost antibody testing. There are many people that are not understanding the difference between COVID-19 swab test and the SARS-CoV-2 Antibody Test. Some of the most significant issues related to Coronavirus infection involve the cardiovascular system.    GUARDaHEART 501(c)3 foundation is actively partnering with community organizations, nonprofit organizations, businesses, and city officials to provide the community with No-Cost COVID-19 Antibody Tests covered under the CARES Act, with or without insurance.  Dr. Douglas Harrington has over 25 years of experience in the research, development, commercialization, and expansion of innovative healthcare technology and services. Dr. Harrington was a member of one of the first heart transplant teams led by Dr. Jack Copeland from Stanford University. Heco-founded one of the first clinical molecular biology laboratories in the U.S. with the Nebraska Lymphoma Study Group headed by Dr. Jim Armitage. As President and Lab Director of Nichols Institute, Dr. Harrington expanded their molecular genetics, infectious disease, immunology, cytogenetic, and anatomic pathology offerings. Dr. Harrington led the team that developed one of the first digital microscopes targeted at minimal residual disease and circulating tumor cells as the founder and CEO of Clarient. Dr. Harrington also led the turnaround and reinstatement of the Federal license of Specialty Laboratories, a New York Stock Exchange company, as CEO and Laboratory Director. This episode is proudly brought to you by:   #Betterhelp : https://www.betterhelp.com/sipod for 10% off  #H2one #Handsanitizer : https://h2one.com/ BUY MERCH!!!!!  #Merch Store: https://www.dckproductions.com/shop Follow me:  https://www.instagram.com/suckitpodcast  https://www.facebook.com/suckitpodcast  https://www.twitter.com/suckit_podcast--- Send in a voice message: https://podcasters.spotify.com/pod/show/thedarksideofmusic/messageSupport this podcast: https://podcasters.spotify.com/pod/show/thedarksideofmusic/support

Unfortunately, there are many people that are asymptomatic with the coronavirus (not exhibiting any signs or symptoms of active infection) Amid this unprecedented crisis, GUARDaHEART Foundation is working with the communities to offer no-cost antibody testing. There are many people that are not understanding the difference between COVID-19 swab test and the SARS-CoV-2 Antibody Test. Some of the most significant issues related to Coronavirus infection involve the cardiovascular system.    GUARDaHEART 501(c)3 foundation is actively partnering with community organizations, nonprofit organizations, businesses, and city officials to provide the community with No-Cost COVID-19 Antibody Tests covered under the CARES Act, with or without insurance.  Dr. Douglas Harrington has over 25 years of experience in the research, development, commercialization, and expansion of innovative healthcare technology and services. Dr. Harrington was a member of one of the first heart transplant teams led by Dr. Jack Copeland from Stanford University. Heco-founded one of the first clinical molecular biology laboratories in the U.S. with the Nebraska Lymphoma Study Group headed by Dr. Jim Armitage. As President and Lab Director of Nichols Institute, Dr. Harrington expanded their molecular genetics, infectious disease, immunology, cytogenetic, and anatomic pathology offerings. Dr. Harrington led the team that developed one of the first digital microscopes targeted at minimal residual disease and circulating tumor cells as the founder and CEO of Clarient. Dr. Harrington also led the turnaround and reinstatement of the Federal license of Specialty Laboratories, a New York Stock Exchange company, as CEO and Laboratory Director. This episode is proudly brought to you by:   #Betterhelp : <a href="https://www.betterhelp.com/sipod" rel="nofollow" target="_blank">https://www.betterhelp.com/sipod</a> for 10% off  #H2one #Handsanitizer : <a href="https://h2one.com/" rel="nofollow" target="_blank">https://h2one.com/</a> BUY MERCH!!!!!  #Merch Store: <a href="https://www.dckproductions.com/shop" rel="nofollow" target="_blank">https://www.dckproductions.com/shop</a> Follow me:  <a href="https://www.instagram.com/suckitpodcast" rel="nofollow" target="_blank">https://www.instagram.com/suckitpodcast</a> <a href="https://www.facebook.com/suckitpodcast" rel="nofollow" target="_blank">https://www.facebook.com/suckitpodcast</a> <a href="https://www.twitter.com/suckit_podcast" rel="nofollow" target="_blank">https://www.twitter.com/suckit_podcast</a>--- Send in a voice message: <a href="https://podcasters.spotify.com/pod/show/thedarksideofmusic/message" rel="nofollow" target="_blank">https://podcasters.spotify.com/pod/show/thedarksideofmusic/message</a> Support this podcast: <a href="https://podcasters.spotify.com/pod/show/thedarksideofmusic/support" rel="payment nofollow" target="_blank">https://podcasters.spotify.com/pod/show/thedarksideofmusic/support</a>